Free press releases distribution network?

More news: Health/Surgery
Agency / Source: IMARC Group

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



High Obesity Levels and Strong Genetic Vulnerability Driving India’s Diabetes Population Finds IMARC Group - With around 78 Million Indians expected to suffer from diabetes by 2020, the market for oral antidiabetic drugs, insulin and diagnostics is expected to witness strong growth - IMARCgroup.com
High Obesity Levels and Strong Genetic Vulnerability Driving India’s Diabetes Population Finds IMARC Group

 

PRZOOM - /newswire/ - New Delhi, Delhi, India, 2014/01/20 - With around 78 Million Indians expected to suffer from diabetes by 2020, the market for oral antidiabetic drugs, insulin and diagnostics is expected to witness strong growth - IMARCgroup.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Increasing obesity levels, high genetic vulnerability and increasing urbanization rates are expected to be the catalysts in driving the prevalence of diabetes in India. Research firm IMARC Group expects India’s diabetes population to increase at a CAGR of 3% during 2013-2020, according to its latest report titled “Indian Diabetes Market Report: Epidemiology, Patients, Prevalence, Oral Anti-diabetics, Insulin and Diagnostics”. The report which has done a comprehensive analysis on the market for diabetic drugs and diagnostics, expects 78 Million Indians to suffer from diabetes by 2020, creating a huge demand for oral antidiabetic drugs, insulin and diagnostics.

According to Sidhartha Kapoor, an analyst at IMARC Group,“the Indian population that had faced under nutrition for a long time is now exposed to high fat diets and sedentary lifestyles. As a result of increasing disposable incomes and flourishing fast food chains, India had an estimated 165 Million overweight and 30 Million obese population in 2013. These levels are expected to increase significantly in the coming years”. Apart from the increasing obesity levels, Kapoor also pointed out that a high genetic vulnerability is also driving the prevalence of diabetes in the country. According to Kapoor- “As a result of a higher percentage of body fat to muscle, Indians are more vulnerable to type-2 diabetes compared to other population groups. This fat increases the sugar levels as it gets deposited around the abdomen and interferes with insulin. As a result, Indians get diabetes at a much younger age compared to other population groups”.

IMARC’s new report “Indian Diabetes Market Report: Epidemiology, Patients, Prevalence, Oral Anti-diabetics, Insulin and Diagnostics” provides an analytical and statistical insight into the Indian diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in India. The report has segmented the Indian diabetes market into three segments - Oral Anti-diabetics, Insulin and Diabetes Diagnostics. For each of the aforementioned categories, the report provides historical and future market sales, performance of key classes and the performance of top players.

The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Indian diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Indian diabetes market in some form or the other.

What we have achieved in this report:

Comprehensive situation analysis of the Indian Diabetes Epidemiology and its dynamics:
Focus of the Analysis:
• Historical, current and future prevalence of diabetes in India
• Historical, current and future prevalence of type-1 and type-2 diabetes in India
• Historical, current and future prevalence of diabetes in the urban and rural regions in India
• Historical, current and future prevalence of diabetes among males and females in India
• Historical, current and future prevalence of diabetes among various age groups in India
• Historical, current and future diagnosis rates for diabetes in India
• Historical, current and future drug treatment rates for diabetes in India

Comprehensive situation analysis of the Indian Oral Anti-diabetics market and its dynamics:
Focus of the Analysis:
• Performance of the Oral Anti-diabetics market in India
• Performance of key classes
• Performance of key players
• Market outlook

Comprehensive situation analysis of the Indian Insulin market and its dynamics:
Focus of the Analysis:
• Performance of the Insulin market in India
• Performance of key classes
• Performance of key players
• Market outlook

Comprehensive situation analysis of the Diabetes Diagnostics market and its dynamics:
Focus of the Analysis:
• Performance of the Diabetes Diagnostics market in India
• Performance of key classes
• Performance of key players
• Market outlook

To buy the complete report or to get a free sample, please contact:

IMARC Group Asia
E: apac[.]imarcgroup.com - P: +91-120-415-5099

IMARC Group North America
E: america[.]imarcgroup.com - P: +1-631-791-1145

IMARC Group Europe, Middle East & Africa
E: ema[.]imarcgroup.com - P: +44-702-409-7331

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: IMARC Group

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


High Obesity Levels and Strong Genetic Vulnerability Driving India’s Diabetes Population Finds IMARC Group

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Krishna Sharma - IMARCgroup.com 
+91 12 04155099 press[.]imarcgroup.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any IMARC Group securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From IMARC Group / Company Profile


Read Health/Surgery Most Recent Related Press Releases:

Sustainable Alternatives to Polyvinylidene Chloride-coated Films Create Growth Opportunities & Transform the Food Packaging Markets in Western Europe
RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan Has Developed A Way to Engineer Glycan Complexes Clusters of Sugar Chains
The Clinicians of Longs Peak Emergency Physicians Join US Acute Care Solutions
Frost & Sullivan Recognizes BroadReach for Improving the Health and Wellbeing of Underserved Populations
Silver Spring Emergency Physicians Join US Acute Care Solutions
Stress Light Therapy Launches Crowd-Funded Campaign on Indiegogo.com
Frost & Sullivan Names Optum 2016 North America Company of the Year for Population Health Management
R-Pharm Produces Biological Drugs in Yaroslavl with GE Healthcare's FlexFactory™ Manufacturing Platform
GE to Invest €150 Million in Biopharmaceutical Manufacturing Campus in Cork, Ireland, and Establish Advanced Manufacturing Training Centre At NIBRT
Ultimate Medical Group Announces A New Regenerative Medicine Division

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  Triggr & Bloom

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today